| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer (NCT06456411) | Roswell Park Cancer Institute | 2022-07-12 |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (NCT05494060) | The First Affiliated Hospital with Nanjing Medical University | 2022-03-16 |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors (NCT05235607) | Sichuan University | 2022-03-01 |
| Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma (NCT05188729) | Verrica Pharmaceuticals Inc. | 2022-02-01 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery (NCT04962958) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-12-27 |
| Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010) (NCT05094882) | Fudan University | 2021-12-01 |
| Registry Platform Ovarian and Endometrial Cancer (NCT05129969) | iOMEDICO AG | 2021-11-25 |
| App Teaches Doctors to Diagnose Skin Cancer (NCT05661370) | Herlev Hospital | 2021-11-15 |
| Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings (NCT04931251) | UNC Lineberger Comprehensive Cancer Center | 2021-11-11 |
| Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study (NCT05463757) | Maastricht University Medical Center | 2021-11-01 |
| ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) (NCT05115500) | Second Affiliated Hospital of Soochow University | 2021-11-01 |
| Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer (NCT05023928) | Sichuan University | 2021-09-01 |
| The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer. (NCT05752357) | Chang Gung Memorial Hospital | 2021-09-01 |
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
| Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 (NCT04787042) | Simcha IL-18, Inc. | 2021-08-06 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients (NCT05375136) | Eisai Korea Inc. | 2021-06-25 |
| Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients (NCT04641819) | ShuGuang Hospital | 2021-04-27 |
| Propofol vs Sevo for Paediatric Tumor Surgery (NCT04475705) | Hong Kong Children's Hospital | 2021-01-11 |
| External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446) | Blueprint Medicines Corporation | 2020-12-01 |
| Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study (NCT04401059) | Tian Xie | 2020-11-09 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| Existential Distress in Patients with Advanced Cancer and Their Caregivers (NCT04600206) | Universitätsklinikum Hamburg-Eppendorf | 2020-10-23 |
| Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer (NCT04362072) | Pfizer | 2020-09-29 |
| Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma (NCT05593744) | Qilu Hospital of Shandong University | 2020-08-17 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer (NCT04419623) | Telios Pharma, Inc. | 2020-07-09 |
| Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma (NCT04429490) | CHU de Reims | 2020-06-12 |
| Smartphone App for Cancer Medication Adherence (NCT05225090) | Columbia University | 2020-01-15 |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease (NCT01125449) | Situs Cancer Research Center | 2020-01-01 |
| A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT03952403) | Shanghai Henlius Biotech | 2019-12-02 |
| Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) (NCT04124731) | Shanghai Chest Hospital | 2019-10-01 |
| Efficacy and Safety of UGN-101 in Recurrent Patients (NCT04006691) | UroGen Pharma Ltd. | 2019-10-01 |
| Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. (NCT04033991) | Pfizer | 2019-09-27 |
| Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer (NCT03857620) | Alliance for Clinical Trials in Oncology | 2019-07-24 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma (NCT04008082) | Eisai Co., Ltd. | 2019-05-14 |
| Multiplex Analysis of Circulating Tumor DNA (NCT03301961) | Peking University People's Hospital | 2019-04-11 |
| Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions (NCT03549273) | Catalysis SL | 2019-03-11 |
| Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT03708224) | Alain Algazi | 2019-03-08 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| Detecting Lung Cancer Based on Exhaled Breath (NCT04419207) | Peking University People's Hospital | 2019-03-01 |
| Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC (NCT03780283) | First Hospital of Shijiazhuang City | 2019-01-01 |
| Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin (NCT03699332) | Radboud University Medical Center | 2018-12-01 |
| Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients (NCT02696525) | Peking University People's Hospital | 2018-12-01 |
| Sym004 Versus Futuximab or Modotuximab in Patients With mCRC (NCT03549338) | Symphogen A/S | 2018-11-29 |
| Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative (NCT03765775) | First Hospital of Shijiazhuang City | 2018-11-20 |
| Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients (NCT03664843) | First Hospital of Shijiazhuang City | 2018-11-09 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer). (NCT03634826) | Peking University People's Hospital | 2018-08-15 |
| Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC) (NCT03240393) | Novartis Pharmaceuticals | 2018-07-31 |
| Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma (NCT03546166) | Centre Hospitalier Universitaire de Nice | 2018-07-26 |
| MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. (NCT03611556) | MedImmune LLC | 2018-06-21 |
| Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO (NCT03515174) | National Cancer Centre, Singapore | 2018-04-16 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line (NCT03288298) | Cairo University | 2017-11-01 |
| Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing (NCT03320044) | Peking University People's Hospital | 2017-10-18 |
| Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients (NCT03331601) | Universitair Ziekenhuis Brussel | 2017-10-16 |
| PEN-866 in Patients With Advanced Solid Malignancies (NCT03221400) | Tarveda Therapeutics | 2017-08-29 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
| Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer (NCT02898116) | Ludwig Institute for Cancer Research | 2017-05-10 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| Ceramide NanoLiposome in Patients With Advanced Solid Tumors (NCT02834611) | Keystone Nano, Inc | 2017-03-15 |
| Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients (NCT02965391) | Peking University People's Hospital | 2016-11-01 |
| A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours (NCT02977364) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2016-11-01 |
| Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study (NCT02907606) | Peking University People's Hospital | 2016-09-01 |
| KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT02867007) | Kyowa Kirin, Inc. | 2016-08-01 |
| ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants (NCT02737501) | Ariad Pharmaceuticals | 2016-05-26 |
| What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors (NCT02840604) | Centre Georges Francois Leclerc | 2016-05-15 |
| Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients (NCT02703298) | TaiRx, Inc. | 2016-03-25 |
| Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors (NCT02705105) | Kyowa Kirin, Inc. | 2016-02-01 |
| Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients (NCT02526953) | Blokhin's Russian Cancer Research Center | 2016-01-01 |
| Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection (NCT02433574) | Juravinski Cancer Center | 2015-11-01 |
| MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC (NCT02592577) | Adaptimmune | 2015-11-01 |
| A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma (NCT02539537) | UNICANCER | 2015-10-23 |
| Radiofrequency Ablation of Malignant Pulmonary Nodules (NCT02629978) | Chinese PLA General Hospital | 2015-10-01 |
| Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors (NCT02567734) | Yueyong Xiao | 2015-10-01 |
| A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer (NCT02507544) | TaiRx, Inc. | 2015-09-01 |
| Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer (NCT02473094) | University of Campinas, Brazil | 2015-07-01 |
| Beyond TME Origins (NCT02292641) | Imperial College London | 2014-09-25 |
| Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly (NCT02151149) | Celgene | 2014-06-09 |
| EBUS-TBNA Versus EBUS-TBNB (NCT01467635) | Royal Brompton & Harefield NHS Foundation Trust | 2014-05-01 |
| Registry for Proton Beam Radiation Therapy (NCT02040467) | Washington University School of Medicine | 2013-12-18 |
| Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab (NCT01345084) | Eurofarma Laboratorios S.A. | 2013-11-01 |
| A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer (NCT01942200) | Onkovis GmbH | 2013-09-01 |
| PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative (NCT01916135) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer (NCT01840280) | Onkovis GmbH | 2013-04-01 |
| Early Diagnosis of Pulmonary Nodules (NCT01752114) | Integrated Diagnostics | 2012-10-01 |
| Identification of a Plasma Proteomic Signature for Lung Cancer (NCT01752101) | Integrated Diagnostics | 2012-10-01 |
| A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer (NCT01668108) | Onkovis GmbH | 2012-08-01 |
| Systems Intervention to Promote Colorectal Cancer (CRC) Screening (NCT01299493) | Washington University School of Medicine | 2012-06-19 |
| A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer (NCT01614002) | Onkovis GmbH | 2012-05-01 |
| Continuous Infusion of rhIL-15 for Adults With Advanced Cancer (NCT01572493) | National Cancer Institute (NCI) | 2012-04-04 |